News
12h
Newspoint on MSN9 Most Common Genetic DisordersYou’ve likely heard people mention that they have inherited certain health conditions from their family. These are known as ...
LAHORE: The Punjab government has made genetic testing, including for thalassemia and other diseases, mandatory for students ...
Thalassemia Test Declared Mandatory for Admission in Educational Institutes and Religious Seminaries
In Punjab, it has been made mandatory for all students to undergo screening for thalassemia and other genetic disorders at ...
It would be for the management of patients with Thalassemia and Sickle Cell Disease responding to a request from Nepal. The Tribune, now published from Chandigarh, started publication on February ...
The following is a summary of “Evaluated NSUN3 in reticulocytes from HbH-CS disease that reflects cellular stress in ...
U.S. Regulatory Filing Under Active Review for Approval of PYRUKYND® (mitapivat) in Thalassemia, with PDUFA Goal Date of September 7, 2025 – – Phase 3 RISE UP Study of Mitapivat in Sickle Cell Disease ...
India has delivered a $2 million consignment of vaccines to Nepal to combat Sickle Cell Disease and Thalassemia, enhancing the country's healthcare efforts. The donation underscores the longstanding ...
Amid a reckoning for the gene therapy field, Vertex Pharmaceuticals has joined a growing list of companies paring back their ...
Agios Pharmaceuticals Inc (AGIO) reports a 6% revenue increase and outlines promising pipeline developments, despite facing ...
PYRUKYND, a pyruvate kinase activator, remains the flagship product with multi-billion-dollar potential. Agios is targeting a U.S. approval for thalassemia by September 7, 2025, and a sickle cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results